Total Payments
$1,188
2022 Payments
$17.89
Companies
11
Transactions
19
Medicare Patients
2,656
Medicare Billing
$373,556
Payment Breakdown by Category
Food & Beverage$1,188 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,188 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $634.70 | 5 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $124.97 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $124.52 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $123.04 | 1 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $66.65 | 4 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $31.61 | 2 | $0 (2020) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $20.20 | 1 | $0 (2020) |
| Vapotherm Inc | $17.89 | 1 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $17.77 | 1 | $0 (2019) |
| CHF Solutions, Inc | $16.80 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $17.89 | 1 | Vapotherm Inc ($17.89) |
| 2021 | $20.35 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($20.35) |
| 2020 | $87.22 | 5 | Janssen Pharmaceuticals, Inc ($31.61) |
| 2019 | $552.99 | 7 | Genentech USA, Inc. ($135.00) |
| 2018 | $509.44 | 5 | Genentech USA, Inc. ($499.70) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/27/2022 | Vapotherm Inc | VAPOTHERM (Device) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: RESPIRATORY | ||||||
| 09/08/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Gastroenterology | ||||||
| 04/08/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), RELISTOR | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/05/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.20 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/03/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/06/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/07/2020 | CHF Solutions, Inc | Aquadex (Device) | Food and Beverage | Cash or cash equivalent | $16.80 | General |
| Category: Cardiology | ||||||
| 12/24/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), RELISTOR | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), RELISTOR | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/22/2019 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $17.77 | General |
| 05/29/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $124.97 | General |
| 03/27/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.52 | General |
| 03/21/2019 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $135.00 | General |
| 03/14/2019 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Food and Beverage | In-kind items and services | $123.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/08/2018 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $136.11 | General |
| Category: Immunology | ||||||
| 07/18/2018 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $140.33 | General |
| 06/28/2018 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $132.46 | General |
| 06/21/2018 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $90.80 | General |
| Category: Immunology | ||||||
| 05/01/2018 | Genentech, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: Metabolism & Primary Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 659 | 1,176 | $297,578 | $97,836 |
| 2022 | 10 | 676 | 1,124 | $278,734 | $94,727 |
| 2021 | 4 | 551 | 914 | $157,495 | $80,060 |
| 2020 | 5 | 770 | 1,119 | $194,155 | $100,933 |
Total Patients
2,656
Total Services
4,333
Medicare Billing
$373,556
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 190 | 520 | $83,720 | $30,706 | 36.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 112 | 222 | $51,282 | $19,467 | 38.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 196 | 207 | $49,059 | $17,360 | 35.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 48 | 111 | $68,154 | $17,099 | 25.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 67 | 69 | $30,981 | $8,681 | 28.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 46 | 47 | $14,382 | $4,524 | 31.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 173 | 453 | $96,786 | $34,653 | 35.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 101 | 104 | $40,018 | $15,535 | 38.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 42 | 81 | $49,256 | $13,391 | 27.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 157 | 166 | $38,766 | $12,901 | 33.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 111 | 217 | $34,815 | $11,596 | 33.3% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 34 | 34 | $4,760 | $2,025 | 42.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $4,590 | $1,431 | 31.2% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 11 | 16 | $3,625 | $1,218 | 33.6% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 13 | 19 | $3,059 | $1,014 | 33.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 19 | 19 | $3,059 | $962.49 | 31.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 164 | 526 | $78,900 | $41,527 | 52.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 148 | 149 | $43,210 | $22,609 | 52.3% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Facility | 2021 | 162 | 162 | $22,680 | $9,690 | 42.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 77 | 77 | $12,705 | $6,234 | 49.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 208 | 538 | $80,700 | $43,661 | 54.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 204 | 206 | $59,740 | $32,265 | 54.0% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Facility | 2020 | 232 | 238 | $33,320 | $14,588 | 43.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 102 | 103 | $16,995 | $8,529 | 50.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 24 | 34 | $3,400 | $1,891 | 55.6% |
About Dr. Dharshan Lakshminarayan, M.D
Dr. Dharshan Lakshminarayan, M.D is a Hospitalist healthcare provider based in Muskogee, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2016. The National Provider Identifier (NPI) number assigned to this provider is 1295198620.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dharshan Lakshminarayan, M.D has received a total of $1,188 in payments from pharmaceutical and medical device companies, with $17.89 received in 2022. These payments were reported across 19 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,188).
As a Medicare-enrolled provider, Lakshminarayan has provided services to 2,656 Medicare beneficiaries, totaling 4,333 services with total Medicare billing of $373,556. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Location Muskogee, OK
- Active Since 04/02/2016
- Last Updated 03/15/2022
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1295198620
Products in Payments
- Xolair (Biological) $136.11
- ZINPLAVA (Biological) $123.04
- Esbriet (Biological) $90.80
- XIFAXAN (Drug) $46.30
- XARELTO (Drug) $31.61
- RELISTOR (Drug) $20.35
- LifeVest (Device) $20.20
- VAPOTHERM (Device) $17.89
- Aquadex (Device) $16.80
- Activase (Biological) $9.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Muskogee
Soumya Kidiyoor, M.d, M.D
Hospitalist — Payments: $2,856
Hospitalist $2,856
Dr. Deepak Karibassappa, Md, MD
Hospitalist — Payments: $2,707
Hospitalist $2,707
Ragan Vaughan, D.o, D.O
Hospitalist — Payments: $725.65
Hospitalist $725.65
Kendall Allmaras
Hospitalist — Payments: $495.74
Hospitalist $495.74
Dr. Jameson Pelton, Do, DO
Hospitalist — Payments: $306.96
Hospitalist $306.96
Dr. Michael Hilborn, Do, DO
Hospitalist — Payments: $301.62
Hospitalist $301.62